Skip to main content

An evaluation of oncofertility decision support resources among breast cancer patients and health care providers



Cancer patients of reproductive age are at risk of infertility as a result of their treatment. Oncofertility decision support resources can assist patients with fertility decision-making before treatment yet available oncofertility resources contain varying levels of detail and different fertility options. The key information/sections needed in oncofertility resources remain unclear. To explore the information needs for oncofertility decision-making before cancer treatment, we aimed to evaluate existing oncofertility decision support resources with breast cancer patients and providers.


We conducted 30 to 90-min interviews that included a survey questionnaire and open-ended questions with patients and providers between March and June 2016. Interviews were transcribed verbatim. Analysis involved descriptive statistics for survey responses and thematic analysis of qualitative data.


A total of 16 participants completed interviews. Key information perceived by most participants as necessary for fertility decision-making included tailored post-treatment pregnancy rates, cost ranges and financial assistance for the fertility options based on patients’ situation. However, patient and provider participants expressed differing opinions on the inclusion of all before and after treatment fertility options and the amount of fertility information required at diagnosis.


The evaluation identified fertility information needs among patients in addition to providers’ views on patient needs. While existing oncofertility resources contain information perceived as necessary for decision-making there is an opportunity to use these findings to create or enhance resources to better meet the needs of patients. Additionally, patients and providers differing views on information needs highlight the opportunity for provider training to ensure better communication using resources in clinic to understand specific patient needs.

Peer Review reports


Cancer patients of reproductive age may experience compromised reproductive function in survivorship as a result of their treatment [1,2,3,4]. Accordingly, these individuals often need to make time-sensitive decisions about pursuing fertility interventions prior to commencing cancer treatments [3]. Fertility guidelines updated in 2018 by the American Society of Clinical Oncology (ASCO) recommend that infertility risks and fertility preservation (FP) options be discussed early with patients and referrals made to specialists and organizations with resources to facilitate fertility decision-making [5].

Decision support resources, such as decision aids, have been recommended as a supplement to discussions to assist patients with fertility decision-making [6,7,8,9,10,11,12]. However, the varying informational needs among patient populations based on their different knowledge levels and experience can create challenges for resource developers [13].

Oncofertility decision support resources for cancer patients of reproductive age are available in various countries and include interactive online tools, brochures, paper and online decision aids, and option grids [11, 14,15,16,17,18]. While oncofertility resources are available, they contain varying levels of detail, cover differing FP and parenthood options, and most do not directly include the option to forgo any fertility intervention. The key information needed for informed fertility-decision making, the content that is most valuable, and optimal formatting (e.g., online, paper, video), and dissemination of oncofertility resources to support patients and health care providers during fertility discussions and decision-making remains unclear. To explore the information needs for oncofertility decision-making before cancer treatment, we aimed to evaluate existing oncofertility decision support resources with breast cancer patients and providers.


The Research Ethics Board (REB) at St. Michael’s Hospital in Toronto, Ontario approved the evaluation (REB#15–220) and ethics was obtained from recruiting sites. All participants provided written and verbal consent prior to participation in the evaluation.

Selection of Oncofertility decision support resources

We reviewed the indexed and grey literature in consultation with oncology and fertility content experts, which identified six patient-focused oncofertility resources for evaluation by Canadian breast cancer patients and providers [15,16,17,18,19]. The six oncofertility resources included two decision aids from Australia [15] and the Netherlands [16], an option grid from Canada [18] and three patient educational materials from the United States [17, 19] (LIVESTRONG fertility booklet, LIVESTRONG Family-Building Option Tool, and the MyOncofertility educational website that is now SaveMyFertility) (Table 1). While other educational materials related to fertility are available for cancer patients [11, 14], the selected oncofertility resources represent a range of detailed resources (e.g., Australian and Dutch decision aids, MyOncofertility educational website), shorter resources (e.g., Canadian option grid, LIVESTRONG booklet and Family-Building Option Tool), and simple and complex resources (e.g. the option grid is a one page tool, the Australian decision aid is a booklet, and the Netherlands decision aid is an interactive online tool). The oncofertility resources contained similar sections (e.g. listing established FP options) but also had unique characteristics (e.g. an explicit values clarification method in the decision aids) (Table 2).

Table 1 Characteristics of the evaluated oncofertility decision support resources
Table 2 Sections and information included in the evaluated oncofertility decision support resources

Sample participants

We recruited breast cancer patients between the age of 18 and 45 who experienced fertility decision-making prior to their fertility-risking treatment within the past five years. Participants were recruited in person at two breast cancer clinics in the Greater Toronto Area and online through Canadian-wide advocacy groups and cancer organizations. Through the research team’s circle of contact and snowball sampling [20] multi-disciplinary health care providers who provide care to young breast cancer patients were also recruited from across Canada.

Data collection

Interviews occurred between March 2016 and June 2016. Participants had the option to complete the interviews in person (for those located in the Greater Toronto Area, Ontario) or by telephone. A structured questionnaire, tailored to the unique features of the six oncofertility resources and role of participant (e.g., patient or provider) was used to conduct the interviews. The guide contained both closed-ended and open-ended questions, which allowed participants to reflect on their experiences and expand on their responses. Closed-ended questions were rated using multiple choice and different 5-point Likert scales depending on the set of questions. For example, participants rated the usefulness of each oncofertility resource section using the scale: 1 = not at all useful, 2 = not very useful, 3 = useful, 4 = very useful, 5 = not sure; participants then rated their level of agreement on the oncofertility resources usability and flow of content using the scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree and 5 = strongly agree; finally participants rated the importance of factors that can impact fertility decision-making on a scale of: 1 = not at all important, 2 = not very important, 3 = important, 4 = very important, 5 = not sure. Participants were also asked to rate the length of oncofertility resources using the scale: 1 = too short, would prefer it to be much longer, 2 = short, would prefer it to be a bit longer, 3 = just right, 4 = long, would prefer it to be a little shorter, 5 = too long, would prefer it to be much shorter; as well as the use of figures in the oncofertility resources using the scale: 1 = too few, would prefer a lot more, 2 = few, would prefer a few more, 3 = just right, 4 = a lot, would prefer a few less, 5 = too many, would prefer a lot less. Questions focused on the content, usability, and design features of the oncofertility resources and the general use of resources (Additional file 1). Prior to the interviews, participants received two of the six oncofertility resources through random assignment (one decision aid and one patient educational material) by email to allow for familiarization of the resources prior to the interview. Evaluations continued until each oncofertility resource was reviewed by at least three participants.

Data analysis

Interviews were audio recorded, transcribed verbatim, and audited by the interviewer to ensure content accurately reflected what was said in the interview. Responses to closed-ended questions were inputted into Microsoft Excel 2016 and frequencies were calculated for each question. Thematic analysis was used to analyze the open-ended responses [21]. Any elaboration by participants on the questions was deductively coded by two team members independent of each other using a coding scheme that reflected the sections and unique content of the oncofertility resources. NVivo 11.2.2 was used to organize the data and facilitate the qualitative analysis. Themes were developed based on common ideas across the six evaluated oncofertility resources and data repetition [21]. Team members and coders met regularly to discuss the coding, analysis, and emerging findings.


A total of 16 interviews were conducted, two in-person and 14 by telephone, with patient participants (n = 8) and provider participants (n = 8) (Table 3). Interviews ranged from 30 to 90 min with most participants evaluating two of the oncofertility resources; five participants only evaluated one resource due to time limitations. However, each oncofertility resource was evaluated by at least three participants.

Table 3 Patient and provider participant characteristics

Utility of oncofertility decision support resource content and format

In general, patient and provider participants perceived the following sections included in the oncofertility resources to be useful (i.e. over 90% of participants rated these sections as ‘useful’ or ‘very useful’): the fertility options before treatment and parenthood options after treatment; availability of financial assistance and cost of each fertility option; the list of additional resources for more information and support; the question list for health care providers; and the glossary of terms. However, participants expressed varied responses on the perceived usefulness of some resource sections including: the option grids to summarize information; the background information sections; the personal stories; the values clarification methods in the decision aids; the ongoing research on fertility and cancer; and the videos, animations, and graphics (Table 4).

Table 4 Sections participants rated as ‘useful’ or ‘very useful’ in the evaluated oncofertility decision support resources

Patient and provider participants also evaluated the usability, readability, and content of each oncofertility resource (Table 5). Most patient and provider participants rated the Australian decision aid (4/5 participants, 80%) and Netherlands decision aid (6/7 participants, 86%) as long or too long, and the LIVESTRONG Family-Building Option Tool as short or too short (4/4 participants, 100%). Patient and provider participants also thought that all oncofertility resources flowed in a logical order (6/6 resources, 100%) and indicated a preference for paper and/or online resources (14/16 participants, 88%) over other format options including audio-guided booklets or videos.

Table 5 Patient and provider participant agreement on the usability, readability and content in the evaluated oncofertility decision support resources

Participants expressed varying opinions on whether the oncofertility resources contained enough information to make an informed fertility decision. Among the participants who reviewed the more detailed resources (e.g., the Australian and the Netherlands decision aids and MyOncofertility educational website) 60% (9/15 participants - eight patient participants and one provider participant) reported that there was enough information for decision-making, whereas only 18% (2/11 patient participants and no provider participants) reported that there was enough information for decision-making in the shorter resources (e.g., the option grid, LIVESTRONG fertility booklet, and LIVESTRONG Family-Building Option Tool). More patient participants (8/9, 89%) also perceived that the detailed resources contained enough information for decision-making, in comparison to provider participants (1/5, 20%).

Preferences for fertility information

Four themes were discerned from the data: challenges on the delivery and use of fertility information in clinical practice; ideal delivery and timing of decision support resources in clinical practice; perspectives of information needs for informed fertility decision-making; and factors influencing FP decisions. Illustrative quotes from patient and provider participants for each theme are presented in Table 6.

Table 6 Themes discerned from the evaluation of oncofertility decision support resources and illustrative quotes from patient and provider participants

Challenges on the delivery and use of fertility information in clinical practice

Patient participants noted that they did not receive enough fertility information when diagnosed with cancer. In instances where information was provided one patient participant described it as ‘piece meal’ and ‘dumped on my lap’. Another patient participant reported that more fertility information before treatment might have changed their final fertility decision. There was belief among patient and provider participants that too much information may overwhelm patients but some patient participants also noted that if fertility was important to them they would take the time to read the information provided. Following clinical appointments all patient participants indicated they had searched for more fertility information online and one used the information found online to initiate a fertility discussion with her oncology health care provider.

Among the provider participants, only a few (2/8, 25%) said they provided patients with oncofertility resources including ones developed specifically for their clinic and on FP financial assistance. The remaining provider participants said they provided verbal fertility information to their patients along with referrals to reproductive specialists. One provider commented that they did not provide oncofertility resources as the decision is often quite emotional for patients and therefore felt resources were unable to help with those emotions in the same way as medical counseling. In addition, a provider participant noted that some oncofertility resources contained misleading information on the fertility options. Role uncertainty was also discussed; some provider participants felt that it was not their role to provide oncofertility resources to patients and were unclear on who was most responsible to provide these resources.

Ideal delivery and timing of decision support resources in clinical practice

Patient and provider participants had mixed opinions on the appropriate time to deliver an oncofertility resource to patients. Some participants recommended that oncofertility resources be delivered as soon as the patient is diagnosed (3 patient participants and 3 provider participants, 38%). Others felt the ideal time point is when discussing the treatment plan (5 patient participants and 4 provider participants, 56%). A few provider participants expressed concerns about early presentation and referrals to reproductive specialists as not all cancer treatment is fertility-risking and patients are often initially overwhelmed by their cancer diagnosis and treatment information. However, it was noted that bringing up fertility information too late may also overwhelm patients. Patient and provider participants also expressed varying views on who should deliver an oncofertility resource; some indicated that the provider with whom the patient had the most rapport would be best; however it was also important that the resource was delivered by a provider who would not bias patients’ decision. In contrast, other participants felt an oncofertility resource should be completed with providers such as medical oncologists (2 patient participants and 2 provider participants, 25%) so that patients can receive specific information on their risks for infertility and/or nurses or social workers (3 patient participants and 2 provider participants, 31%) so patients can have access to psychological counseling as they make their decision.

Perspectives of information needs for informed fertility decision-making

Patient and provider participants identified the specific background and fertility-related information, sections, and features necessary for informed decision-making (Fig. 1). Information included: (1) age-and treatment-related declines in fertility; (2) cancer treatments that impact fertility; (3) menopause and other possible fertility outcomes after treatment; (4) post-treatment pregnancy rates with each fertility option; and (5) health of children born to cancer survivors and conceived using FP. The inclusion of accurate cost ranges for the FP options as well as financial assistance programs were noted as important to include to ensure patients are not shocked or disappointed following FP.

Fig. 1

Summary of recommended information, sections, and features for inclusion in oncofertility decision support resources

Patient and provider participants had differing opinions on the inclusion of other information in oncofertility resources including: (1) pregnancy at the time of a breast cancer diagnosis; (2) genetic testing; (3) breastfeeding; (4) contraception; and (5) menstrual cycles. Patient participants who did not have this information during their decision-making felt it was important to include in an oncofertility resource. On the other hand, provider participants noted that including information that did not directly contribute to fertility decision-making prior to treatment could cause more confusion or unrealistic expectations among patients. Mixed opinions were also noted on the inclusion of experimental FP options; patient participants preferred having all options listed while provider participants expressed concern that these options were not available universally across Canada. If experimental FP options were included participants stated that they should be presented after established FP options. Some participants suggested including fewer FP options upfront with other options as supplementary information for those who desired additional information. While most patient and provider participants felt parenthood options after cancer treatment would be useful to include, some provider participants thought it was too much information and felt most patients were knowledgeable on the options following treatment.

With respect to values clarification methods and personal stories in oncofertility resources, notably while many participants (64 and 83% respectively) rated them as useful, some expressed concerns with this information. Specifically, there was concern that personal stories might influence patients to choose the same option as the storyteller if similarities were present in their experiences. Provider participants also noted that an explicit values clarification method with many prelisted factors may overwhelm patients; however, patients preferred the prelisted factors to use as a starting point for their decision-making. While some patient participants found the values clarification method a useful way to break down and solidify their fertility decision, others felt that they were not in line with how they typically processed information and made decisions and therefore did not believe it would be useful. Additionally, while option grids with simple information were noted as a useful starting point for decision-making, provider participants advised that they do not encompass all the aspects of fertility decisions (e.g., emotional aspects of care) and thus were not considered adequate as a stand-alone resource for patients.

Overall, content in the oncofertility resources that repeated information already provided to patients during other parts of their care journey (e.g. prevalence and general breast cancer facts), or that used heavy text and high-level language was not seen to be of value by patient or provider participants. Patient and provider participants noted that content and graphics included in oncofertility resources should be diverse and inclusive of all family-types. Patient participants also wanted information on the pregnancy success rates and cost of FP tailored to their situation vs. general information. Most oncofertility resources evaluated lacked references (5/6, 83%), and this caused provider participants to have limited trust in the information, particularly when it differed from their understanding of the topic.

Factors influencing FP decisions

Many factors were seen to influence fertility decision-making by patients and providers. Key factors highlighted by participants included:

  • Stage and severity of the cancer diagnosis

  • Time required to complete FP

  • Chance of a cancer recurrence

  • Cost of the FP options

  • Outcomes for children conceived using FP and pregnancy success rates of the FP options

  • Desire for biological children

  • Pregnancy at diagnosis and current children

  • Patient’s age

  • Relationship status

  • Experience completing FP prior to the diagnosis

  • Factors involved in the FP procedure (e.g., invasive component)

  • Support (e.g., emotional) from providers and support person(s) (e.g., partners who may share in the decision-making on FP with patients)

  • Distance from hospital to FP clinics

  • General feelings of being overwhelmed

Common factors agreed on by most participants included the stage and severity of the cancer diagnosis, time required to complete FP, and the accurate cost of FP as the decision was perceived as more complex if no funding is available.


This study aimed to evaluate six oncofertility resources to explore, understand, and describe the fertility information needs among patients from the perspective of breast cancer patients with the experience of FP decision-making and providers. The use of existing oncofertility resources as a reference for participants allowed for a more thorough understanding of information needs as patient participants drew from past experiences and discussed information in the resources never mentioned to them but that they found valuable. To our knowledge, this is the first evaluation of patient-focused oncofertility resources with patient and provider participants. This evaluation provides insights into the specific information, sections, and formatting that should be considered when developing oncofertility resources for cancer patients of reproductive age. It also highlights that in general existing oncofertility resources contain information that meets the needs of young breast cancer patients; however, not all information in the resources was perceived as necessary for informed decision-making.

The fertility information needs among cancer patients in Australia has been explored prospectively by Peate et al. [22], and this evaluation found that in addition to general information on the impact of cancer treatment and fertility patients perceived factors impacting fertility such as age related declines are valuable when making fertility decisions. The findings from a qualitative study with young breast cancer patients by Thewes et al. [8], showed that patients had questions on the pregnancy rates after treatment, available fertility options, success rates of FP, risk of cancer recurrence after pregnancy and use of contraception, similar to participants in this evaluation. This evaluation also highlighted the perceived value of tailored pregnancy success rates and cost/funding information to the patients situation (e.g., age and location), and various components of oncofertility resources that are useful such as an option grid summary, additional resources, a glossary, a reference page to encourage trust in the information presented, and a health care provider directed question list.

Participants felt that supplementary information (e.g., experimental FP options) should be accessible based on each patient’s information needs due to the variability in needs between individuals. Our findings also show that information should be inclusive of various family types and avoid high-level language, which can be achieved by adhering to plain language best practices [23,24,25] to ensure understanding by patients. The factors influencing FP decisions found in this evaluation can be utilized with specific internal and external factors identified by other studies, such as Jones et al. [6], to create sections in oncofertility resources such as an explicit values clarification method.

Patient and provider participants expressed different opinions in the evaluation on the amount of information to include in oncofertility resources (for example on genetic testing and breastfeeding) and the inclusion of all before treatment and after treatment fertility options. Most patients generally prefer to receive information from their providers during their clinical encounters [26], and Peate et al., note that many patients prefer to make fertility decisions after consideration of their providers opinions or through shared decision-making [22]. Therefore, differences in the perception of information needs by providers and patients may affect the quality of information presented to patients, limiting some patients’ ability to make a fully informed decision. The differing opinions highlight the potential role for enhanced communication in clinical settings with the use of oncofertility resources to ensure providers understand each patient’s information needs. Additionally, these different opinions can prove difficult when designing resources in general as developers often have to decide on whose views to utilize for the different sections [13, 27]. As such, there may be a role in bringing patients and providers together for collaborative discussions on information needs to inform the content for inclusion in resources.

The evaluation showed the preferred format for a resource among participants was online and/or paper and both formats have been shown to be effective for patient education [28]. However, through this evaluation there were mixed opinions on how oncofertility resources should be completed and distributed in clinic and who should deliver resources. Some provider participants cited role confusion as a barrier to the provision of fertility information. The 2018 ASCO fertility guidelines target a range of providers, highlighting the need for interdisciplinary involvement in oncofertility counseling and shared decision-making [5]. However, no single provider type is identified as ultimately responsible for discussing FP with patients, which poses a potential challenge in the information delivery process that can result in patients receiving limited or no information and/or conflicting responses between different providers [29]. Effective strategies for the delivery of oncofertility resources with consideration to current care pathways and roles in clinical settings can help ensure patients are receiving resources before making fertility decisions.

The creation and use of oncofertility resources is recommended in the literature to ensure appropriate information delivery to patients, referrals to reproductive specialists, and to improve information retention among patients [7, 8, 10,11,12, 30,31,32,33,34]. Based on the evaluation results, training for health care providers on oncofertility and shared decision-making may result in a better understanding of patient information needs and value of resources. In addition, we feel the evaluation results should be considered when creating/modifying oncofertility resources and highlight the need for a new Canadian specific resource that adopts the aspects perceived as valuable in existing resources.

However, there are limitations to this evaluation. While provider participants worked in academic and community hospitals across Canada, most patient participants were treated in Ontario potentially limiting the transferability of results to other locations. Participants also included patients who already made their fertility decision, which may have limited their ability to recall what information would have benefited them at the time of decision-making or increased their estimation on the amount of information they would have wanted at the time of their diagnosis based on their current knowledge. However, similar to other studies [35, 36] we did not approach newly diagnosed patients as the review of oncofertility resources from other countries may have caused them to feel conflicted on the relevant information/ fertility options for them in Canada. Additionally, all patient participants had completed at minimum post-secondary education; information needs among low literacy patients may vary from those identified in this evaluation. Planned future work to inform oncofertility resources should aim to recruit individuals with lower literacy [23]. Interviews with patient’s partners were not completed for this evaluation. However, patient’s partners and family generally have some level of involvement in the multiple stages of cancer decision-making [37]. Future research would benefit from the partners perspective and identification of information needs when involved in FP decisions and how they compare to the needs of patients as well as, how partners communicate to mutually come to a fertility decision that is right for their family. Finally, the transferability of results may be limited due to the low overall sample size of participants and the unique nature of information needs for each patient based on their situation and experiences [13, 38]. Despite these limitations, each oncofertility resource was evaluated by at least three participants to help determine the key information that should be considered when creating a resource. Additionally, our research provides important insight into the information needs among young breast cancer patients when making fertility decisions.


Through the evaluation of existing oncofertility resources by patient and provider participants, the information perceived as important for informed fertility decision-making was identified and summarized. In general, participants perceived the existing oncofertility resources for cancer patients of reproductive age to be useful for informed fertility decision-making. However, there was also information and sections within existing oncofertility resources that participants felt was not necessary for decision-making. While many resources undergo testing throughout development [15, 16], this is the first study that allows patients and providers to view multiple resources allowing for comparisons and a better understanding of how oncofertility content can be delivered in decision aids and patient educational materials. The information reported in this evaluation can be used to inform future development and use of resources for patients facing fertility decisions. Additionally, the evaluation highlighted the differing perceived information needs among patients and providers suggesting that training for health care providers and better communication is required in clinical settings with the use of oncofertility resources to understand specific needs among patients.



American Society of Clinical Oncology


Fertility Preservation


Research Ethics Board


  1. 1.

    Fleischer RT, Vollenhoven BJ, Weston GC. The effects of chemotherapy and radiotherapy on fertility in premenopausal women. Obstetrical Gynecolog Surv. 2011;66(4):248–54.

    Article  Google Scholar 

  2. 2.

    Blumenfeld Z. Chemotherapy and fertility. Best Prac Res Clin Obstet Gynaecol. 2012;26(3):379–90.

    Article  Google Scholar 

  3. 3.

    Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917–31.

    Article  Google Scholar 

  4. 4.

    Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14(1):1.

    Article  Google Scholar 

  5. 5.

    Oktay K, Harvey BE, Partridge AH, et al. Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology. 2018;0(0):JCO.2018.2078.1914.

  6. 6.

    Jones G, Hughes J, Mahmoodi N, Smith E, Skull J, Ledger W. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment? Hum Reprod Update. 2017;23(4):433–57.

    Article  Google Scholar 

  7. 7.

    Yee S. Factors associated with the receipt of fertility preservation services along the decision-making pathway in young Canadian female cancer patients. J Assist Reprod Genet. 2016;33(2):265–80.

    Article  Google Scholar 

  8. 8.

    Thewes B, Meiser B, Taylor A, et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast Cancer. J Clin Oncol. 2005;23(22):5155–65.

    CAS  Article  Google Scholar 

  9. 9.

    Ronn R, Holzer HEG. Oncofertility in Canada: an overview of Canadian practice and suggested action plan. Curr Oncol. 2013;20(5):e465–74.

    CAS  Article  Google Scholar 

  10. 10.

    Ehrbar V, Urech C, Alder J, et al. Decision-making about fertility preservation—qualitative data on young cancer patients’ attitudes and needs. Arch Womens Ment Health. 2016;19(4):695–9.

    Article  Google Scholar 

  11. 11.

    Quinn GP, Vadaparampil ST, Sehovic I, Clayman ML. Patient and family tools to aid in education and decision-making about oncofertility. Oncofertility Communication: Springer; 2014. p. 35–47.

    Google Scholar 

  12. 12.

    Baysal Ö, Bastings L, Beerendonk C, et al. Decision-making in female fertility preservation is balancing the expected burden of fertility preservation treatment and the wish to conceive. Hum Reprod. 2015;30(7):1625–34.

    CAS  Article  Google Scholar 

  13. 13.

    Feldman-Stewart D, O’Brien MA, Clayman ML, et al. Providing information about options in patient decision aids. BMC Med Inform Decis Mak. 2013;13(2):S4.

    Article  Google Scholar 

  14. 14.

    Kelvin JF, Leah Kroon MNR, Ogle SK. Fertility preservation for patients with cancer. Clin J Oncol Nurs. 2012;16(2):205.

    Article  Google Scholar 

  15. 15.

    Peate M, Meiser B, Friedlander M, et al. Development and pilot testing of a fertility decision aid for young women diagnosed with early breast cancer. Breast J. 2011;17(1):112–4.

    Article  Google Scholar 

  16. 16.

    Garvelink MM, ter Kuile MM, Fischer MJ, et al. Development of a decision aid about fertility preservation for women with breast cancer in the Netherlands. J Psychosom Obstet Gynecol. 2013;34(4):170–8.

    Article  Google Scholar 

  17. 17.

    Jona KG. Adam. a web-based patient education resource supporting decision making under severe emotional and cognitive overload. Cancer Treat Res. 2010;156:345–61.

    Article  Google Scholar 

  18. 18.

    Women's College Research Institute. SPOKE (surgeon and patient Oncofertility knowledge enhancement) physician and patient option grids. 2015; Accessed 18 Mar 2017.

    Google Scholar 

  19. 19.

    LIVESTRONG. LIVESTRONG Fertility. 2015; Accessed 18 Mar 2017.

  20. 20.

    Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522–6.

    CAS  Article  Google Scholar 

  21. 21.

    Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.

    Article  Google Scholar 

  22. 22.

    Peate M, Meiser B, Friedlander M, et al. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with breast cancer—an Australian fertility decision aid collaborative group study. J Clin Oncol. 2011;29(13):1670–7.

    Article  Google Scholar 

  23. 23.

    McCaffery KJ, Holmes-Rovner M, Smith SK, et al. Addressing health literacy in patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S10.

    Article  Google Scholar 

  24. 24.

    Patient Education Group. Maximizing your patient education skills part II: developing patient education materials. Toronto: St. Michael's Hospital; 2015.

    Google Scholar 

  25. 25.

    Brega A, Barnard J, Mabachi N, et al. AHRQ health literacy universal precautions toolkit. Rockville: Agency for Healthcare Research and Quality; 2015.

    Google Scholar 

  26. 26.

    Goossens J, Delbaere I, Van Lancker A, Beeckman D, Verhaeghe S, Van Hecke A. Cancer patients’ and professional caregivers’ needs, preferences and factors associated with receiving and providing fertility-related information: a mixed-methods systematic review. Int J Nurs Stud. 2014;51(2):300–19.

    Article  Google Scholar 

  27. 27.

    Savelberg W, van der Weijden T, Boersma L, Smidt M, Willekens C, Moser A. Developing a patient decision aid for the treatment of women with early stage breast cancer: the struggle between simplicity and complexity. BMC Med Inform Decis Mak. 2017;17(1):112.

    CAS  Article  Google Scholar 

  28. 28.

    Wilson EA, Makoul G, Bojarski EA, et al. Comparative analysis of print and multimedia health materials: a review of the literature. Patient Educ Couns. 2012;89(1):7–14.

    Article  Google Scholar 

  29. 29.

    Quinn GP, Vadaparampil ST. More research, more responsibility: the expansion of duty to warn in cancer patients considering fertility preservation. Am J Obstet Gynecol. 2013;209(2):98–102.

    Article  Google Scholar 

  30. 30.

    Partridge AH, Gelber S, Peppercorn J, et al. Web-based survey of fertility issues in young women with breast Cancer. J Clin Oncol. 2004;22(20):4174–83.

    Article  Google Scholar 

  31. 31.

    Penrose R, Beatty L, Mattiske J, Koczwara B. The psychosocial impact of cancer-related infertility on women: a review and comparison. Clin J Oncol Nurs. 2013;17(2):188.

    Article  Google Scholar 

  32. 32.

    Meneses K, McNees P, Azuero A, Jukkala A. Development of the fertility and Cancer project: an internet approach to help young cancer survivors. Oncol Nurs Forum. 2010;37(2):191–7.

    Article  Google Scholar 

  33. 33.

    Yee S, Fuller-Thomson E, Lau A, Greenblatt EM. Fertility preservation practices among Ontario oncologists. J Cancer Educ. 2012;27(2):362–8.

    Article  Google Scholar 

  34. 34.

    Ronn R, Holzer HEG. Oncofertility in Canada: the impact of cancer on fertility. Curr Oncol. 2013;20(4):e338–44.

    CAS  Article  Google Scholar 

  35. 35.

    Garvelink MM, ter Kuile MM, Bakker RM, et al. Women's experiences with information provision and deciding about fertility preservation in the Netherlands: ‘satisfaction in general, but unmet needs’. Health Expect. 2015;18(5):956–68.

    Article  Google Scholar 

  36. 36.

    Peate M, Meiser B, Hickey M, Friedlander M. The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic review. Breast Cancer Res Treat. 2009;116(2):215.

    Article  Google Scholar 

  37. 37.

    Laidsaar-Powell R, Butow P, Bu S, et al. Family involvement in cancer treatment decision-making: A qualitative study of patient, family, and clinician attitudes and experiences. Patient Educ Couns. 2016;99(7):1146–55.

    Article  Google Scholar 

  38. 38.

    Robinson OC. Sampling in interview-based qualitative research: a theoretical and practical guide. Qual Res Psychol. 2014;11(1):25–41.

    Article  Google Scholar 

Download references


Gratitude goes to the breast cancer patients and health care providers who shared their opinions and experiences in this evaluation.


This research was funded by the Canadian Cancer Society (grant #702601). The funder had no role in the study design, data collection, analysis and interpretation, or the writing the manuscript.

Availability of data and materials

Transcripts from patient and provider interviews are confidential and are not publically available.

Author information




BS contributed to the recruitment, interview completion, data analysis and drafting of the manuscript. AS assisted with participant recruitment, data analysis, and drafting of the manuscript. CD participated in the design of the evaluation and drafting of the manuscript. MF contributed to the study design, data analysis, and drafting of this manuscript. EK and KM assisted with data analysis, identification of oncofertility resources, and drafting of this manuscript. NB conducted the design of the study and assisted in drafting of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Nancy N. Baxter.

Ethics declarations

Ethics approval and consent to participate

Ethics was obtained from St. Michael’s Hospital in Toronto, Ontario (REB#15–220) and recruiting sites. All participants provided written and verbal consent prior to participation in the evaluation.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1:

Interview Guide S1. Example interview guide for patient participants (Australian Decision Aid). (DOCX 28 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Speller, B., Sissons, A., Daly, C. et al. An evaluation of oncofertility decision support resources among breast cancer patients and health care providers. BMC Health Serv Res 19, 101 (2019).

Download citation


  • Decision aids
  • Patient education material
  • Fertility
  • Breast cancer
  • Decision-making
  • Information needs
  • Evaluation